A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

Overview[ - collapse ][ - ]

Purpose To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118) in combination with Metformin in pediatric patients with type 2 diabetes
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Placebo matching with Saxagliptin
Drug: Metformin IR
Drug: Metformin XR
Drug: Saxagliptin
Drug: Saxagliptin
PhasePhase 3
SponsorBristol-Myers Squibb
Responsible PartyBristol-Myers Squibb
ClinicalTrials.gov IdentifierNCT01434186
First ReceivedSeptember 13, 2011
Last UpdatedApril 16, 2014
Last verifiedApril 2014

Tracking Information[ + expand ][ + ]

First Received DateSeptember 13, 2011
Last Updated DateApril 16, 2014
Start DateMay 2012
Estimated Primary Completion DateJuly 2017
Current Primary Outcome MeasuresMean change in Glycosylated hemoglobin (HbA1c) in the short term treatment period [Time Frame: Baseline and upto Week 16 (or the last post-baseline measurement prior to Week 16, if no Week 16 assessment is available)] [Designated as safety issue: No]
Current Secondary Outcome Measures
  • Mean change in 2-hour Postprandial Glucose (PPG) Area under the curve (AUC) in the short term treatment period [Time Frame: Baseline and upto Week 16 (or the last post-baseline measurement prior to Week 16, if no Week 16 assessment is available)] [Designated as safety issue: No]
  • Mean change in FPG (Fasting plasma glucose) in the short term treatment period [Time Frame: Baseline and upto Week 16 (or the last post-baseline measurement prior to Week 16, if no Week 16 assessment is available)] [Designated as safety issue: No]
  • Percent of subjects with HbA1c < 7% in the short term treatment period [Time Frame: At Week 16 (or the last post-baseline measurement prior to Week 16, if no Week 16 assessment is available)] [Designated as safety issue: No]

Descriptive Information[ + expand ][ + ]

Brief TitleA Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Official TitleA Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination With Metformin IR or Metformin XR in Pediatric Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Brief Summary
To evaluate the efficacy, safety, tolerability, of Saxagliptin (BMS-477118) in combination
with Metformin in pediatric patients with type 2 diabetes
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Placebo matching with Saxagliptin
Tablet, Oral, 0.0 mg, Daily, Day 1 through week 52
Drug: Metformin IR
Tablet, Oral, 1000 mg -2000 mg, Daily , Day 1 through week 52
Drug: Metformin XR
Tablet, Oral, 1000 mg -2000 mg, Daily, Day 1 through week 52
Drug: Saxagliptin
Tablet, Oral, 2.5 mg for body weight 30kg to ≤ 50kg, Daily, Day 1 through week 52
Other Names:
BMS-477118Drug: Saxagliptin
Tablet, Oral, 5 mg for the body weight >50 kg, Daily, Day 1 through week 52
Other Names:
BMS-477118
Study Arm (s)
  • Experimental: Arm 1: Saxagliptin + Metformin IR
  • Experimental: Arm 2: Placebo for Saxagliptin + Metformin IR
  • Experimental: Arm 3: Saxagliptin + Metformin XR
  • Experimental: Arm 4: Placebo for Saxagliptin + Metformin XR

Recruitment Information[ + expand ][ + ]

Recruitment StatusRecruiting
Estimated Enrollment224
Estimated Completion DateJuly 2017
Estimated Primary Completion DateSeptember 2016
Eligibility Criteria
Inclusion Criteria:

- Male and female patients eligible if 10 years of age, up to 17 years and 30 weeks of
age at the time of screening

- Previously diagnosed as having type 2 diabetes

- HbA1c ≥7.0% and ≤10.5%

- Body weight ≥ 30 kg

- Stable dose of metformin (≥ 1000mg - ≤ 2000mg) for a minimum of 2 months

- Women must have a negative serum or urine pregnancy test

- Women must not be breastfeeding

Exclusion Criteria:

- Current use of anti-diabetic medications or use within the specified timeframe prior
to screening (Exception: Metformin)

- Fasting plasma glucose (FPG) > 255 mg/dL

- Diabetic ketoacidosis (DKA) within 6 months of study entry

- Abnormal renal function

- Active liver disease

- Anemia

- An abnormal Thyroid Stimulating Hormone (TSH)

- Creatinine kinase (CK) ≥ 3X ULN
GenderBoth
Ages10 Years
Accepts Healthy VolunteersNo
ContactsContact: Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:
Clinical.Trials@bms.com
Location CountriesUnited States, Argentina, Belgium, Canada, India, Israel, Italy, Mexico, South Africa, Taiwan, United Kingdom

Administrative Information[ + expand ][ + ]

NCT Number NCT01434186
Other Study ID NumbersCV181-147
Has Data Monitoring CommitteeYes
Information Provided ByBristol-Myers Squibb
Study SponsorBristol-Myers Squibb
CollaboratorsAstraZeneca
Investigators Study Director: Bristol-Myers Squibb Bristol-Myers Squibb
Verification DateApril 2014

Locations[ + expand ][ + ]

Uab Pediatric Endocrinology
Birmingham, Alabama, United States, 35233
Contact: Gail Mick, Site 1051 | 205-996-9569
Recruiting
Neufeld Medical Group
Los Angeles, California, United States, 90048
Contact: Naomi Neufeld, Site 1039 | 310-652-2531
Recruiting
Local Institution
Sacramento, California, United States, 95819
Contact: Site 1002
Not yet recruiting
Rady Children'S Hospital - San Diego
San Diego, California, United States, 92123
Contact: Ron Newfield, Site 1012 | 858-966-8940
Recruiting
Local Institution
Ventura, California, United States, 93003
Contact: Site 1042
Not yet recruiting
Local Institution
Aurora, Colorado, United States, 80045
Contact: Site 1034
Not yet recruiting
Local Institution
Boca Raton, Florida, United States, 33432
Contact: Site 1008
Not yet recruiting
Miami Children'S Hospital
Miami, Florida, United States, 33155
Suspended
Local Institution
Miami, Florida, United States, 33125
Contact: Site 1024
Not yet recruiting
Wright, Nancy
Tallahassee, Florida, United States, 32308
Contact: Nancy Wright, Site 1015 | 850-656-3361
Recruiting
Emory Healthcare-Children'S Hospital
Atlanta, Georgia, United States, 30322
Suspended
Columbus Research Foundation
Columbus, Georgia, United States, 31904
Contact: Steven Leichter, Md, Site 5306 | 706-322-1700
Recruiting
Local Institution
Chicago, Illinois, United States, 60611
Contact: Site 1016
Not yet recruiting
Local Institution
Olympia Fields, Illinois, United States, 60461
Contact: Site 1045
Not yet recruiting
Alzohaili Medical Consultants
Dearborn, Michigan, United States, 48124
Contact: Opada Alzohaili, Site 1043 | 313-581-8903
Recruiting
Childrens Hospitals And Clinics Of Minnesota
St. Paul, Minnesota, United States, 55102
Contact: Mary Jennifer Abuzzahab, Site 1032 | 651-220-6254
Recruiting
Local Institution
Columbia, Missouri, United States, 65212
Contact: Site 1033
Not yet recruiting
Local Institution
Saint Louis, Missouri, United States, 63110
Contact: Site 1049
Not yet recruiting
Local Institution
Billings, Montana, United States, 59101
Contact: Site 1000
Not yet recruiting
Local Institution
Hackensack, New Jersey, United States, 07601
Contact: Site 1041
Not yet recruiting
Local Institution
Livingston, New Jersey, United States, 07039
Contact: Site 1036
Not yet recruiting
Local Institution
New Brunswick, New Jersey, United States, 08901
Contact: Site 1025
Not yet recruiting
Local Institution
Buffalo, New York, United States, 14222
Contact: Site 1001
Not yet recruiting
Winthrop University Hospital
Mineola, New York, United States, 11501
Contact: Siham Accacha, Site 1031 | 516-663-9582
Recruiting
Local Institution
Athens, Ohio, United States, 45701
Contact: Site 1013
Not yet recruiting
Local Institution
Cleveland, Ohio, United States, 44195
Contact: Site 1035
Not yet recruiting
Local Institution
Columbus, Ohio, United States, 43205
Contact: Site 1006
Not yet recruiting
Local Institution
Oklahoma City, Oklahoma, United States, 73103
Contact: Site 1030
Not yet recruiting
Local Institution
Memphis, Tennessee, United States, 38103
Contact: Site 1007
Not yet recruiting
Local Institution
Memphis, Tennessee, United States, 38119
Contact: Site 1052
Not yet recruiting
Local Institution
Dallas, Texas, United States, 75390
Contact: Site 1020
Not yet recruiting
Local Institution
Galveston, Texas, United States, 77555
Contact: Site 1017
Not yet recruiting
Local Institution
Plano, Texas, United States, 75093
Contact: Site 1053
Not yet recruiting
The University Of Texas Health Sci Ctr-San Antonio
San Antonio, Texas, United States, 78284
Suspended
Local Institution
Richmond, Virginia, United States, 23219
Contact: Site 1018
Not yet recruiting
Local Institution
Rosario, Santa Fe, Argentina, 2000
Suspended
Local Institution
Buenos Aires, Argentina, C1425DUC
Suspended
Local Institution
Brussel, Belgium, 1090
Suspended
Local Institution
Bruxelles, Belgium, 1020
Contact: Site 3205
Recruiting
Local Institution
Leuven, Belgium, 3000
Contact: Site 3203
Recruiting
Local Institution
Yvoir, Belgium, 5530
Contact: Site 3200
Recruiting
Local Institution
Calgary, Alberta, Canada, T3B 6A8
Contact: Site 1101
Recruiting
Local Institution
Visakhapatnam, Andhra Pradesh, India, 530002
Contact: Site 4105
Not yet recruiting
Local Institution
Visakhapatnam, Andhra Pradesh, India, 530002
Contact: Site 4104
Not yet recruiting
Local Institution
Mysore, Karnataka, India, 570010
Contact: Site 4109
Not yet recruiting
Local Institution
Bangalore, India, 560003
Contact: Site 4108
Recruiting
Local Institution
Chennai, India, 600013
Contact: Site 4101
Not yet recruiting
Local Institution
Hubli, India, 580023
Contact: Site 4110
Not yet recruiting
Local Institution
Mysore, India, 570011
Contact: Site 4103
Not yet recruiting
Local Institution
Beer-sheva, Israel, 84101
Contact: Site 5000
Recruiting
Local Institution
Jerusalem, Israel, 91240
Contact: Site 5001
Not yet recruiting
Local Institution
Petah Tikva, Israel, 49202
Contact: Site 5004
Recruiting
Local Institution
Ramat Gan, Israel, 52621
Contact: Site 5003
Recruiting
Local Institution
Bari, Italy, 70124
Suspended
Local Institution
Chieti, Italy, 66100
Contact: Site 3002
Not yet recruiting
Local Institution
Firenze, Italy, 50139
Contact: Site 3003
Not yet recruiting
Local Institution
Latina, Italy, 04100
Contact: Site 3001
Recruiting
Local Institution
Milano, Italy, 20157
Contact: Site 3011
Not yet recruiting
Local Institution
Milano, Italy, 20133
Suspended
Local Institution
Modena, Italy, 41100
Contact: Site 3009
Not yet recruiting
Local Institution
Napoli, Italy, 80138
Contact: Site 3004
Not yet recruiting
Local Institution
Palermo, Italy, 90127
Contact: Site 3008
Not yet recruiting
Local Institution
Roma, Italy, 00165
Contact: Site 3007
Not yet recruiting
Local Institution
Torino, Italy, 10126
Contact: Site 3000
Not yet recruiting
Local Institution
Monterrey, Nuevo Leon, Mexico, 64710
Contact: Site 2001
Not yet recruiting
Local Institution
Merida, Yucatan, Mexico, 97070
Contact: Site 2005
Not yet recruiting
Local Institution
Aguascalientes, Mexico, 20230
Contact: Site 2008
Not yet recruiting
Local Institution
Durango, Mexico, 34270
Contact: Site 2006
Not yet recruiting
Local Institution
Mexico D. F., Mexico, 6700
Contact: Site 2009
Not yet recruiting
Local Institution
Veracruz, Mexico, 91910
Contact: Site 2003
Not yet recruiting
Local Institution
Benoni, Gauteng, South Africa, 1500
Contact: Site 5202
Not yet recruiting
Local Institution
Eersterus, Gauteng, South Africa, 0022
Contact: Site 5207
Recruiting
Local Institution
Pretoria, Gauteng, South Africa, 0084
Contact: Site 5205
Recruiting
Local Institution
Dundee, Kwa Zulu Natal, South Africa, 3000
Contact: Site 5201
Not yet recruiting
Local Institution
Durban, Kwa Zulu Natal, South Africa, 4001
Contact: Site 5307
Recruiting
Local Institution
Thabazimbi, Limpopo, South Africa, 0380
Suspended
Local Institution
Parow, Western Cape, South Africa, 7550
Contact: Site 5203
Not yet recruiting
Local Institution
Taichung, Taiwan, 404
Contact: Site 4201
Not yet recruiting
Local Institution
Taipei, Taiwan, 100
Contact: Site 4202
Recruiting
Local Institution
Sheffield, South Yorkshire, United Kingdom, S10 2TH
Contact: Site 3105
Not yet recruiting
Local Institution
Birmingham, West Midlands, United Kingdom, B4 6NH
Contact: Site 3101
Recruiting
Local Institution
Leicester, United Kingdom, LE15WW
Contact: Site 3106
Not yet recruiting
Local Institution
Manchester, United Kingdom, M13 9WL
Contact: Site 3100
Recruiting